Compile Data Set for Download or QSAR
Found 35 Enz. Inhib. hit(s) with all data for entry = 50039601
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380736(CHEMBL2017828)copy SMILEScopy InChI
Affinity DataIC50: 4.24nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380725(CHEMBL2017832)copy SMILEScopy InChI
Affinity DataIC50: 9.90nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(RAT)
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)copy SMILEScopy InChI
Affinity DataIC50: 14.7nMAssay Description:Displacement of [125I]-CCK-2 from rat CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)copy SMILEScopy InChI
Affinity DataIC50: 20.3nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)copy SMILEScopy InChI
Affinity DataIC50: 23.6nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380726(CHEMBL2017833)copy SMILEScopy InChI
Affinity DataIC50: 36nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380730(CHEMBL2017691)copy SMILEScopy InChI
Affinity DataIC50: 36.9nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380724(CHEMBL2017831)copy SMILEScopy InChI
Affinity DataIC50: 38.1nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380735(CHEMBL2017827)copy SMILEScopy InChI
Affinity DataIC50: 44.7nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380729(CHEMBL2017690)copy SMILEScopy InChI
Affinity DataIC50: 49.3nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380731(CHEMBL2017692)copy SMILEScopy InChI
Affinity DataIC50: 68.6nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380734(CHEMBL2017826)copy SMILEScopy InChI
Affinity DataIC50: 80.1nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380727(CHEMBL2017834)copy SMILEScopy InChI
Affinity DataIC50: 87.6nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380722(CHEMBL2017829)copy SMILEScopy InChI
Affinity DataIC50: 93.3nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380721(CHEMBL2017825)copy SMILEScopy InChI
Affinity DataIC50: 168nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380733(CHEMBL2017824)copy SMILEScopy InChI
Affinity DataIC50: 248nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380723(CHEMBL2017830)copy SMILEScopy InChI
Affinity DataIC50: 340nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380732(CHEMBL2017823)copy SMILEScopy InChI
Affinity DataIC50: 373nMAssay Description:Displacement of [125I]-CCK-2 from human CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380736(CHEMBL2017828)copy SMILEScopy InChI
Affinity DataEC50:  256nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380735(CHEMBL2017827)copy SMILEScopy InChI
Affinity DataEC50:  84.2nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380734(CHEMBL2017826)copy SMILEScopy InChI
Affinity DataEC50:  494nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380733(CHEMBL2017824)copy SMILEScopy InChI
Affinity DataEC50:  1.67E+3nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380732(CHEMBL2017823)copy SMILEScopy InChI
Affinity DataEC50:  560nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380731(CHEMBL2017692)copy SMILEScopy InChI
Affinity DataEC50:  1.31E+3nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380730(CHEMBL2017691)copy SMILEScopy InChI
Affinity DataEC50:  400nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380729(CHEMBL2017690)copy SMILEScopy InChI
Affinity DataEC50:  52.5nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)copy SMILEScopy InChI
Affinity DataEC50:  123nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)copy SMILEScopy InChI
Affinity DataEC50:  25.4nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380727(CHEMBL2017834)copy SMILEScopy InChI
Affinity DataEC50:  669nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380726(CHEMBL2017833)copy SMILEScopy InChI
Affinity DataEC50:  12.9nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380725(CHEMBL2017832)copy SMILEScopy InChI
Affinity DataEC50:  2.70nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380724(CHEMBL2017831)copy SMILEScopy InChI
Affinity DataEC50:  380nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380723(CHEMBL2017830)copy SMILEScopy InChI
Affinity DataEC50:  421nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380721(CHEMBL2017825)copy SMILEScopy InChI
Affinity DataEC50:  2.12E+3nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50380722(CHEMBL2017829)copy SMILEScopy InChI
Affinity DataEC50:  31.9nMAssay Description:Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubati...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35VP4PubMed